Preconception metabolic indicators predict gestational diabetes and offspring birthweight

Gynecological Endocrinology

Volumn 30, Issue 11, 2014, Pages 840-844

  Harville, Emily W ^a   Juonala, Markus ^b   Viikari, Jorma S A ^b   Raitakari, Olli T ^c  

^a TULANE UNIVERSITY   (United States)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Birth weight; Diabetes; Fetal growth retardation; Gestational; Waist circumference

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL ASSESSMENT TOOL; DISEASE REGISTRY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LARGE FOR GESTATIONAL AGE; LIPID ACCUMULATION PRODUCT INDEX; MACROSOMIA; MAJOR CLINICAL STUDY; METABOLISM; PARITY; PREGNANCY DIABETES MELLITUS; PROGENY; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE; DIABETES, GESTATIONAL; FETAL MACROSOMIA; GLUCOSE TOLERANCE TEST; PHYSIOLOGY; PREGNANCY; YOUNG ADULT;

ADULT; BIRTH WEIGHT; BODY MASS INDEX; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; GLUCOSE TOLERANCE TEST; HUMANS; PREGNANCY; RISK FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84910033228     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.937336     Document Type: Article

References (36)

1. Kanaka-Gantenbein C, Mastorakos G, Chrousos GP. Endocrinerelated causes and consequences of intrauterine growth retardation. Ann N Y Acad Sci 2003;997:150-7.
2. Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci 2006;1092:138-47.
3. Herring SJ, Oken E. Obesity and diabetes in mothers and their children: can we stop the intergenerational cycle? Curr Diab Rep 2011;11:20-7.
4. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med 2008;21:149-57.
5. Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 2007;30 Suppl 2:S246-50.
6. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation 2010;122:579-84.
7. Gunderson EP, Quesenberry Jr. CP, Jacobs Jr. DR, et al. Longitudinal study of prepregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus: The CARDIA study. Am J Epidemiol 2010;172:1131-43.
8. Hedderson MM, Darbinian JA, Quesenberry CP, Ferrara A. Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus. Am J Obstet Gynecol 2011;205:55.e1-7.
9. Ovesen P, Rasmussen S, Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstet Gynecol 2011;118:305-12.
10. Bartha JL, Gonzalez-Bugatto F, Fernandez-Macias R, et al. Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 2008;137:178-84.
11. Bo S, Menato G, Gallo ML, et al. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 2004;83:335-40.
12. Chatzi L, Plana E, Pappas A, et al. The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus. Diabetes Metab 2009;35:490-4.
13. Ju H, Rumbold AR, Willson KJ, Crowther CA. Borderline gestational diabetes mellitus and pregnancy outcomes. BMC Pregnancy Childbirth 2008;8:31.
14. Feinberg JH, Magann EF, Morrison JC, et al. Does maternal hypoglycemia during screening glucose assessment identify a pregnancy at-risk for adverse perinatal outcome? J Perinatol 2005; 25:509-13.
15. Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2010;89:700-4.
16. Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 2008;87:134-45.
17. Kahn HS: The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005;5:26.
18. Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring) 2010;18:1836-44.
19. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care 2006;29:151-3.
20. Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010;9:45.
21. Wehr E, Gruber HJ, Giuliani A, et al. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab 2011;96:E986-90.
22. Brisson D, Perron P, Kahn HS, et al. The lipid accumulation product for the early prediction of gestational insulin resistance and glucose dysregulation. J Womens Health (Larchmt) 2013;22:362-7.
23. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis 2011;10:88.
24. Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010;33:920-2.
25. Raitakari OT, Juonala M, Ronnemaa T, et al. Cohort profile: The Cardiovascular Risk in Young Finns Study. Int J Epidemiol 2008;37: 1220-6.
26. Porkka KV, Raitakari OT, Leino A, et al. Trends in serum lipid levels during 1980-1992 in children and young adults. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol 1997; 146:64-77.
27. Raiko JR, Viikari JS, Ilmanen A, et al. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med 2010;267: 370-84.
28. Antuna-Puente B, Disse E, Rabasa-Lhoret R, et al. How can we measure insulin sensitivity/resistance? Diabetes Metab 2011;37: 179-88.
29. Pi-Sunyer X. The metabolic syndrome: how to approach differing definitions. Med Clin North Am 2007;91:1025-40.
30. Sandhofer A, Iglseder B, Paulweber B, et al. Comparison of different definitions of the metabolic syndrome. Eur J Clin Investig 2007;37: 109-16.
31. Taverna MJ, Martinez-Larrad MT, Frechtel GD, Serrano-Rios M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 2011;164:559-67.
32. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011;10:183.
33. The SAS Institute: SAS/STAT (R) User's Guide: ROCCONTRAST Statement, 2014, 2014.
34. Hedderson MM, Williams MA, Holt VL, et al. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol 2008;198:409.e1-7.
35. Mohammadreza B, Farzad H, Davoud K, Fereidoun Prof AF. Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol 2012;11:20.
36. Teperi J. Multi-method approach to the assessment of data quality in the Finnish Medical Birth Registry. J Epidemiol Community Health 1993;47:242-7.